Compare SPRY & KODK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SPRY | KODK |
|---|---|---|
| Founded | 2015 | 1880 |
| Country | United States | United States |
| Employees | N/A | 3500 |
| Industry | Biotechnology: Pharmaceutical Preparations | Business Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 788.5M | 805.8M |
| IPO Year | 2020 | 1994 |
| Metric | SPRY | KODK |
|---|---|---|
| Price | $6.02 | $8.17 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $40.00 | N/A |
| AVG Volume (30 Days) | ★ 2.3M | 705.6K |
| Earning Date | 05-11-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | $84,278,000.00 | ★ $4,114,000,000.00 |
| Revenue This Year | $87.40 | N/A |
| Revenue Next Year | $81.64 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $5.77 | $4.94 |
| 52 Week High | $18.63 | $14.87 |
| Indicator | SPRY | KODK |
|---|---|---|
| Relative Strength Index (RSI) | 28.16 | 41.57 |
| Support Level | N/A | $8.01 |
| Resistance Level | $8.61 | $9.01 |
| Average True Range (ATR) | 0.44 | 0.30 |
| MACD | -0.18 | 0.06 |
| Stochastic Oscillator | 13.90 | 73.66 |
ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the commercialization and development of neffy (currently identified in the European Union (EU) and United Kingdom (U.K.) by the trade name EURneffy and in China) for needle-free intranasal delivery of epinephrine for emergency treatment of Type I allergic reactions, including anaphylaxis. Neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows Neffy to safely provide intranasal delivery of epinephrine at a low dose within the exposures of approved injectable products across a range of dosing conditions.
Eastman Kodak Co is a United States-based company. It operates through several business segments; Print, Brand, and Advanced Materials and Chemicals. The Print segment which derives the majority of revenue includes products like digital offset plate offerings and computer-to-plate imaging solutions, high-quality digital printing solutions using electrically charged toner-based technology, production press systems, consumables, inkjet components, software and services. Geographically, the company generates revenue from the United States, Canada, Europe, Middle East and Africa, Asia Pacific, and Latin America.